Biodesix tests are covered by Medicare and many commercial health plans. It's our goal to ensure access to patients who may benefit from our tests.

veristrat test logo

The VeriStrat® blood-based proteomic test provides predictive and prognostic information for patients diagnosed with advanced non-small cell lung cancer (NSCLC).​

genestrat test logo

The GeneStrat® blood-based genomic portfolio provides guideline-recommended actionable mutations for patients with NSCLC​ to expedite time to treatment.

genestrat ngs test logo

The GeneStrat NGS test is a blood-based assay utilizing Next Generation Sequencing (NGS) methodology to assess cell-free nucleic acids from patients with advanced cancer.


The Nodify CDT® blood-based lung nodule test helps identify patients with a higher risk of malignancy that can be prioritized for diagnostic intervention, potentially avoiding delays in lung cancer diagnoses and find cancer sooner.

nodify xl2 logo

The Nodify XL2® blood-based lung nodule test helps identify patients with a lower risk of malignancy that can be safely monitored with follow-up CT scans, potentially alleviating patient anxiety and avoiding unnecessary invasive diagnostic procedures.